key: cord-0793554-ekkgcy93 authors: Azim, Kazi Faizul; Ahmed, Sheikh Rashel; Banik, Anik; Rahman Khan, Md Mostafigur; Deb, Anamika; Somana, Saneya Risa title: Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach date: 2020-06-09 journal: Inform Med Unlocked DOI: 10.1016/j.imu.2020.100367 sha: 9a304f19579a5896d1d25cd73057be2ef76b428d doc_id: 793554 cord_uid: ekkgcy93 The sudden outbreak of novel coronavirus has caused a global concern due to its infection rate and mortality. Despite extensive research, there are still no specific drugs or vaccines to combat SARS-CoV-2 infection. Hence, this study was designed to evaluate some plant-based active compounds for drug candidacy against SARS-CoV-2 by using virtual screening methods and various computational analyses. A total of 27 plant metabolites were screened against SARS-CoV-2 main protease proteins (MPP), Nsp9 RNA binding protein, spike receptor binding domain, spike ecto-domain and HR2 domain using a molecular docking approach. Four metabolites, i.e., asiatic acid, avicularin, guajaverin, and withaferin showed maximum binding affinity with all key proteins in terms of lowest global binding energy. The crucial binding sites and drug surface hotspots were unravelled for each viral protein. The top candidates were further employed for ADME (absorption, distribution, metabolism, and excretion) analysis to investigate their drug profiles. Results suggest that none of the compounds render any undesirable consequences that could reduce their drug likeness properties. The analysis of toxicity pattern revealed no significant tumorigenic, mutagenic, irritating, or reproductive effects by the compounds. However, withaferin was comparatively toxic among the top four candidates with considerable cytotoxicity and immunotoxicity. Most of the target class by top drug candidates belonged to enzyme groups (e.g. oxidoreductases hydrolases, phosphatases). Moreover, results of drug similarity prediction revealed two approved structural analogs of Asiatic acid i.e. Hydrocortisone (DB00741) (previously used for SARS-CoV-1 and MERS) and Dinoprost-tromethamine (DB01160) from DrugBank. In addition, two other biologically active compounds, Mupirocin (DB00410) and Simvastatin (DB00641) could be an option for the treatment of viral infections. The study may pave the way to develop effective medications and preventive measure against SARS-CoV-2. Due to the encouraging results, we highly recommend further in vivo trials for the experimental validation of our findings. The sudden outbreak of novel coronavirus (SARS-CoV-2) infection emanated from Wuhan, China and spread throughout the world excepting a few countries to date [1] . The virus is responsible for causing novel disease, which WHO officially called COVID-19. As of April 23, 2020, World Health Organization (WHO) estimated that new coronavirus touched 213 countries, areas or territories [2, 3] . The infection rate is increasing. However, the fatality rate of SARS-CoV-2 (3.4%) estimated by WHO is lower than previous fatal diseases SARS and MERS, which had 9.6% and 35% death rates, respectively [4, 5] . Coronaviruses are enveloped, positive single-stranded RNA viruses with large genome size ranging from 26 kb to 32 kb. These viruses are representative of four subfamilies, which include alpha-, beta-, gamma-and delta-coronaviruses. SARS-CoV-2 showed more sequence similarity with SARS-CoV than MERS-CoV when genome sequences of these mentioned viruses were compared [6] . But they also exhibit dissimilarities that can influence their process of pathogenesis [7, 8] . SARS-CoV-2 infects humans through the same entry point of the ACE receptor which is expressed in the respiratory tract [9, 10] . However, among various proteins, four proteins are commonly found in the structure of all coronaviruses representing spike (S), envelope (E), membrane (M), and nucleocapsid (N) [8] . The initial and important stage of viral entry into host cell is receptor recognition [11] . The assembly of viral particle involves M protein and E protein, while virus binding and entrance into host cell take place by S protein with the assistance of SARS-CoV-2 angiotensin-converting enzyme [10, 12] . The coronavirus (SARS-CoV-2) belongs to the family of Beta-coronaviruses, which are responsible for causing severe human respiratory syndrome [3, 13] . The virus is spread mainly through community transmission, while SARS and MERS affect people via nosocomial spread [14] . It can transmit from one individual to other by respiratory droplets. SARS-CoV-2 infected patients have general signs and symptoms, suffering initially from common flu-like fever, sputum production, dyspnoea, headache, sore throat/pharyngalgia, and diarrhoea, which may further lead to express life-threatening symptoms including fatal pneumonia [15] . COVID-19 affected patients, either symptomatic or asymptomatic, were detected with the nose area containing a higher viral load than in throat [16] . A critically ill patient has a series of complexities with progression of disease. The efficacy and safety of antivirals require evaluation by clinical trial [3] . There is no efficient, safe, and specific potential therapeutic to be approved for rapid remedy of this new respiratory syndrome to date [17, 18] . Clinical trials of some drugs have been started, yet till now, only a few candidates have shown some efficacy in in vitro studies [19] . Not many have progressed to randomized animal or human trials; hence they may have limited use to counter infection [19] . Many countries and some pharmaceutical companies announced their headway and programs to develop vaccines (e.g. subunit, mRNA, DNA, live-vector vaccine) against the virus. But the developmental process of making human vaccine from concept to licensure may require years [20] . As the epidemic is still spreading, medicinal plants may be alternatively used in making drugs as early as possible. Several scientific researchers reported the helpfulness of plants due to their medicinal value and therapeutic uses as drugs from the ancient times [21] . Plantderived active compounds of different plant parts are useful for treating diseases including diarrhoea, headache, and inflammation, and bacterial and fungal infections. From prehistoric times, traditional people utilized these plants for the remedial purposes of health deteriorating diseases because of the existence of numerous phytochemicals [22] . Various limitations are associated with modern treatment options including drugresistance, severe side effects, adverse toxicity profiles, complicated medication etc. Natural products have the potential to form the basis of holistic health care [23] . The properties of antioxidants render medicinal plants to be effective in treating lifethreatening diseases such as cancer, Alzheimer's disease, diabetes, malaria, and cardiac diseases (Table 1) while minimizing drug toxicity [24] . The expansion of natural product as new medicine or drug to resist the emerging virus SARS-CoV-2 could be done to bypass the side effects of synthetic drugs. Therefore, the study aimed at evaluating some plant-based active compound for drug candidacy against SARS-CoV-2 through virtual screening methods and various computational investigations. The 3D structures of SARS-CoV-2 main proteases (6W63, 6LU7), Nsp9 (Non-structural Molecular docking is an effective approach for screening suitable therapeutics against specific drug target of deadly pathogens [54] . This powerful tool is used to model the interaction between small ligands and macromolecules, thereby paving the way for drug discovery [55] . The binding affinity of 27 plant metabolites with different SARS-CoV-2 proteins/protein domains (drug targets/macromolecules) were determined by using the PatchDock server [56] . Recently, alpha-ketoamide (CID 6482451) has been suggested as a SARS-CoV-2 MPP inhibitor by experimental study [57] . The ligand was used as a positive control for the present study, and employed for docking analysis against all six macromolecules. The docked complexes were further refined via the FireDock refinement tool [58] . The ligand bond complexes were visualized by Discovery Studio v3.1 and PyMOL v2.0 [59,60]. The drug surface hotspot of SARS-CoV-2 proteins was analyzed by investigating the docked complexes with the top metabolites using LigPlot+, Discovery Studio and PyMOL v.2.0 software [59, 60] . Binding patterns of asiatic acid, avicularin, guajaverin, and withaferin with six macromolecules were allowed for comparative structural analysis. Moreover, interaction of Alpha-ketoamide with the studied proteins were also investigated. Absorption, distribution, metabolism, and excretion (ADME) are four major criteria that influence the drug levels and kinetics of drug exposure to the tissues within an organism. The pharmacological activity and performance of a drug is largely controlled by these parameters [61] . The SwissADME server was used to assess the ADME properties of top four metabolites [62] . The BOILED-Egg model was employed to calculate the bloodbrain barrier (BBB) in the studied compounds [63] . The relative toxicity of top drug candidates were analysed via the ProToxII server [64] . This popular webserver efficiently predicts various toxicity endpoints by incorporating molecular similarity, fragment tendency and fragment similarity methods. The server also predicted the oral toxicity based on the analysis of two-dimensional (2D) similarity to compounds with a known median lethal doses (LD50). The set used for the prediction consists of approximately 38,000 unique compounds with known oral LD50 values measured in rodents [65] . Additionally, OSIRIS Property Explorer were employed to investigate the undesired effects of these compounds [66] . SwissTargetPrediction was utilized to estimate the possible macromolecular targets of predicted drug candidates [67] . The server predicts based on a combination of 2D and 3D similarity with a library of 370000 known bioactive compounds on approximately 3000 proteins. Moreover, the SwissSimilarity web tools were used to identify potential drug molecules against SARS-CoV-2 based on homology screening of predicted top drug candidates. The server allowed ligand-based virtual screening of several libraries of small molecules to find approved, experimental, or commercially available drugs from DrugBank using different approaches including FP2 fingerprints, electroshape, spectrophores, and align-IT [68] . All of the retrieved structures of SARS-CoV-2 proteins/protein-domains (macromolecules) and plant metabolites (ligands) were optimized and employed for molecular docking to predict the affinity between the above-mentioned ligands and the macromolecules. The metabolites were ranked based on global binding energy and the results depict that the top four scorers (metabolites) were the same for each of the macromolecules in terms of minimum binding energy (Table 2 and Supplementary File 1). In each case, asiatic acid, avicularin, guajaverin, and withaferin showed the best binding interactions with six studied macromolecules ( Fig. 1 and Table 2 kcal/mol, respectively ( Fig. 3 and Table 2 ). The structural conformation of the docked complex was analysed to unravel the drug surface hotspot of studied SARS-CoV-2 proteins. The ligand binding pattern and interacting residues with their respective positions were investigated ( Different ADME properties, i.e., physicochemical parameters, pharmacokinetics, lipophilicity, water solubility, medicinal chemistry of top drug candidates were estimated to evaluate their drug profiles ( Fig. 4 and Table 3 ). Analysis of inhibition effects with different CYP isoforms (CYP1A2, CYP2D6, CYP2C9, CYP2C19, CYP3A4) revealed that none of the candidates had such an interaction possibility with any cytochromes P450 isoforms. GI absorption was found higher for asiatic acid and withaferin, while lower for guajaverin and avicularin. Moreover, blood-brain barrier (BBB) permeation was calculated by the BOILED-Egg model, which revealed no BBB permeant among the studied top drug candidates. Each candidate was water soluble from a moderate to high level, while guajaverin and avicularin showed maximum solubility (Table 3) . Prediction of various toxicity endpoints such as acute toxicity, hepatotoxicity, cytotoxicity, carcinogenicity, mutagenicity, immunotoxicity, adverse outcomes (Tox21) pathways and toxicity targets were analysed (Table 4) . Results revealed that guajaverin and avicularin fell in the category of toxicity class 5, while the predicted toxicity group for Asiatic acid and withaferin were 4 and 2 respectively (the lower the class the higher the toxicity). Estimated LD50 for asiatic acid, avicularin, guajaverin and withaferin were 2000, 5000, 5000 and 7mg/kg respectively. The toxicity radar in Fig. 5 illustrates the confidence of positive toxicity results compared to the average of its class. None of the compounds showed any undesired effects such as tumorigenicity, mutagenicity, irritating, or reproductive effects. Withaferin, however, was found to be relatively toxic among the four candidates, with considerable cytotoxicity and immunotoxicity (Fig. 5) . Most of the target class belonged to enzymes, kinase proteins, oxidoreductases (i.e. aldose reductase, aldo-keto reductase), phosphatases and lyases (i.e. carbonic anhydrase) ( Fig. 6 and Table 5 ). Ligand-based virtual screening was performed to predict biologically active small compounds against SARS-CoV-2 from DrugBank. Two approved drugs, Hydrocortisone (DB00741) and Dinoprost-tromethamine (DB01160) were found analogous to asiatic acid with prediction scores of 50.52 and 50.53, respectively. Moreover, results revealed the similarity of Mupirocin (DB00410) and Simvastatin (DB00641) with withaferin, with a high prediction score ( Table 6 ). The findings suggest that these could be potential drug candidates against SARS-CoV-2, thus requiring further experimental trials. Excessive infection rates and mortality of SARS-CoV-2 led the researchers to concentrate immensely on developing strategies for combating infections caused by the pathogen [69] [70] [71] . Regardless of this praiseworthy initiative, there are still no specific drugs or approved vaccines that could treat SARS-CoV-2 infected patients [72, 73] . Though some candidates are in the investigational stages, many of them raise controversial issues [74, 75] . Plant-derived natural products play a significant role by being a lead molecule in the development of drug candidates [76] . Hence, in the present study, attempts were taken to evaluate some plant-derived metabolites as inhibitory agents of SARS-CoV-2 based on their binding affinities to the key proteins of the pathogen. The contribution of computational biology has accelerated the pace of drug discovery [77] . It is now used in the biopharmaceutical industry to discover and develop new lead compounds against many infectious pathogens [77, 78] . By this route, one can visualize the possibilities of binding of potential small molecules as ligands/inhibitors [76] . Phytomolecules like Baicalein, Luteolin, Quercetin, and Kaempferol are potential antiviral agents against a wide range of important viruses including Dengue, HIV, H5N1 influenza A virus, Coxsackie virus, CHIKV, and Japanese encephalitis virus [79] . Recent studies have focused on MPP inhibitors of SARS-CoV-2 i.e. alpha-ketoamide, Hydroxy, Remdesivir, Chloroquine and Favipiravir to evaluate their potency as drugs [80, 81] . Several in silico strategies were also adopted to screen putative drug candidates against SARS-CoV-2 [82, 83] . However, all these experiments used either main protease proteins or RNA-dependent RNA polymerase of SARS-CoV-2 as probable drug targets. In this study, we screened some natural metabolites against SARS-CoV-2 main proteases (6W63, 6LU7), Nsp9 (Non-structural protein-9) RNA binding protein (6W4B), spike receptor binding domain (6M0J), spike ecto-domain (6VYB), and HR2 domain (6LVN) using a molecular docking approach [84] [85] [86] . The polyproteins of coronavirus are cleaved and transformed in mature non-structural proteins (Nsp) by proteases [87] . virus-cell membrane fusion [88] . Thus, all of these proteins represent an attractive pharmacological target for SARS-CoV-2. Results revealed that asiatic acid had highest binding affinity with SARS-CoV-2 main protease (-53.05 kcal/mol), Nsp9 RNA binding protein (-50.04 kcal/mol) and spike ectodomain (60.68 kcal/mol) ( Fig. 2 and Table 2 ). Remarkably, four metabolites i.e. asiatic acid, avicularin, guajaverin and withaferin scored best for each six macromolecules and bound with minimum global binding energy (Table 2 and Supplementary File 1). The scores of top candidates were either close or in some instances lower than alpha ketoamide, a positive control used in the present study (Table 2) . Asiatic acid, a triterpenoid derivative from Centella asiatica, displayed antioxidative, anti-inflammatory, and protective properties against neurotoxicity induced by glutamate-or b-amyloid previously [89] . Bian et al. also reported the inhibitory activities of asiatic acid and effectivity against fibroproliferative disorders (Keloids) through blocking the TGFβ/Smad pathway [90] . Withanolides are nature-derived secondary metabolites produced in Withania somnifera via oxidation of steroids, which have medicinal value like antiinflammation, anti-cancer, adaptogenic and anti-oxidant effects [91] . Withaferin, a steroidal lactone from this group, suppresses HIV-1 LTR transcription and viral replication and also has a vital function to inhibit herpes simplex virus [92, 93] . It has anti-inflammatory properties and also shows neuro-protective activity against Aβ neurotoxicity [94, 95] . A molecular docking and simulation study revealed the vital function of withaferin to attenuate the neuraminidase of H1N1 influenza virus [96] . Guajaverin (Quercetin 3-arabinopyranoside) and avicularin (quercetin-3-O-α-Larabinofuranoside) are the main bioactive components of guava leaves with hypoglycemic properties and inhibitory capacity against free fatty acid release [97] . Previously, anti-plaque activity of guajaverine was attributed to its microbicidial activity against the growth of Strep [38] . Avicularin, a flavonoid of plants, displayed diverse pharmacological properties such as anti-inflammatory effects and anti-infectious effects against pathogens [98, 99] . Lee et al. reported the effective anti-oxidant potentiality of Avicularin from Lespedeza cuneata [100] . Researchers also identified hepatoprotective activity of avicularin extracted from the aerial parts of Lespedeza cuneata against lesions caused by t-BHP in HepG2 cells [101] . It has also been suggested to inhibit activation of ERK signaling pathways through LPS-stimulated overproduction of pro-inflammatory mediators and cytokine [98] . Avicularin may suppress the inflammatory response, and causes apoptosis in human RA synovial cells through obstructing the activation of the MEK/NF-κB pathway, thus preventing rheumatoid arthritis (RA) in vitro [102] . In the present study, we revealed the molecular interactions of top drug candidates with SARS-CoV-2 key proteins (Fig. 2, Fig. 3 and Table 2 ). The binding sites for each ligand occupied the catalytic domain of SARS-CoV-2 main protease protein [103] . Among the common binding residues, His41 and Cys145 form the catalytic dyad and act as a substrate recognition site [103, 104] . The top candidates were well fitted into the active pocket of MPP where several hydrophobic amino acid residues including Met49, Gly143, Cys145, Met165, Pro168, Ala191 compose a relatively hydrophobic environment, which may help to stabilize its conformation [104] . The crucial binding sites of Nsp9 protein (39-73 region) are characterized by positively charged, glycine rich β-loops, which were proposed to be involved in RNA binding [105] . Moreover, we targeted three distinct domains of SARS-CoV-2 spike protein, all of which play essential roles in the mechanism of viral entry into the host cell [106] . The investigation may be useful to unravel the main drug target hotspot and medicinal chemistry of the investigational drugs currently under trials against SARS-CoV-2. ADME data, whether experimentally measured or computationally predicted, provide key insights into how a drug will ultimately be treated or accepted by the body. Hence, while a drug lead may exhibit phenomenal efficacy in vitro, poor ADME results often invariably terminate its development [107] . Computational methods play a key role in anticipating potential ADME and toxicity problems and reducing the number of experiments that involve animal testing. Therefore, the topmost drug candidates were employed for ADME analysis to investigate their drug profiles. None of the metabolites, however, showed any undesirable consequences that could reduce their drug likeness properties. SARS-CoV-2 appears as a severe acute respiratory disease not a neuro disease [108] . Thus, there is no need to permeate the blood brain barrier (BBB) for being an effective molecule against SARS-CoV-2. However, no BBB permeants were found among the top drug candidates. Most of the target class for the top drug candidates belonged to the categories of enzymes (e.g. oxidoreductases, hydrolase, phosphatases, lyases ( Table 5 ). The major protease proteins (protein hydrolase) of SARS-CoV-2 thus can be a specific target for these natural metabolites. Guajaverin and avicularin are two isomers and derivatives of quercetin with a glycoside substituent in their chemical structure [109, 110] . The significant similarity between these two polar compounds in terms of structure, chemical formula, molar mass, and other physicochemical parameters (Table 3 ) may be responsible for covering the same targets by these two flavonoids ( Table 5 ). The toxicity of drug impurities is closely related to their structure. Structure-activity relationships (SARs) have been widely used in Europe and the United States to predict toxicity by computer [111] . The toxicity prediction results in the present study revealed negligible tumorigenic, mutagenic, irritating, or reproductive effects by the drug candidates, though withaferin was found to be comparatively toxic among the top four compounds. Despite having medicinal importance [112, 113] , the ability of withaferin to inhibit cell growth and induce apoptosis in in vitro and in vivo models were reported [114, 115] . Moreover, dose dependent toxicity and other adverse effects such as elevation of liver enzymes, skin rash, fever etc. were observed by researchers [115, 116] . Our study also revealed the hepatotoxic and cytotoxic nature of withaferin through computational investigations. However, drug similarity prediction identified two approved structural analogs of withaferin, Mupirocin (DB00410) and Simvastatin (DB00641) which could be alternative choices, and therefore require further in vivo investigations. Ligand-based virtual screening using asiatic acid predicted two other biologically active compounds, Hydrocortisone (DB00741) and Dinoprost-tromethamine (DB01160) from DrugBank. Interestingly, Hydrocortisone, a cortisone based drug, was previously used during the SARS-CoV-1 and MERS outbreak [117] . Diosmin, on the contrary, is used as a supplementary drug and is found in various natural plants [118] . Myricetin showed the potential to inhibit reverse transcriptase of the RLV and HIV viruses, while characterized as having antioxidative and prooxidative properties. It is also a potent anticarcinogen and antimutagen [119] . The most significant finding of this study is Simvastatin, which can block downstream molecules (key factors in virus infectivity) and can control severe influenza and pneumonia through prevention of excess cytokine release [120] . The results suggest that all these compounds could be potential drug candidates against SARS-CoV-2. The study may pave the way to develop effective medications and preventive measures against SARS-CoV-2 in the future. The results suggest that asiatic acid, avicularin, and guajaverin could be options to treat SARS-CoV-2 associated infections. Furthermore, two biologically active structural analogs from DrugBank i.e. Hydrocortisone and Simvastain may be effective and show potency against the viral pathogen. However, all the investigational drugs of SARS-CoV-2 are under strict regulation by the World Health Organization. Due to the encouraging results, we highly recommend further in vivo trials for the experimental validation of our findings. Systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option World Health Organization. Coronavirus disease (COVID-19) Pandemic 2020 Coronavirus disease 2019 (COVID-19): a clinical update The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status SARS and MERS: recent insights into emerging coronaviruses Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan Hemalatha K COVID-19 (Novel Coronavirus 2019) -recent trends Genotype and phenotype of COVID-19: Their roles in pathogenesis A pneumonia outbreak associated with a new coronavirus of probable bat origin Receptor recognition mechanisms of coronaviruses: a decade of structural studies Function, and Evolution of Coronavirus Spike Proteins Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS The COVID-19 epidemic A Novel Coronavirus Emerging in China -Key Questions for Impact Assessment CoV-2: an Emerging Coronavirus that Causes a Global Threat SARS-CoV-2 viral load in upper respiratory specimens of infected patients Drug treatment options for the 2019-new coronavirus (2019-nCoV) Therapeutic options for the 2019 novel coronavirus (2019-nCoV) COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics Accelerating vaccine development and deployment: report of a Royal Society satellite meeting The potential medicinal value of plants from Asteraceae family with antioxidant defense enzymes as biological targets Bioactive compounds, health benefits and utilization of Rhododendron: a comprehensive review The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases Herbal versus synthetic drugs; beliefs and facts Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review Natural Antioxidant: An Update The Therapeutic Potential of Apigenin Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise Avicularin ameliorates human hepatocellular carcinoma via the regulation of NF-κB/COX-2/PPAR-γ activities Capsaicin: A review of its pharmacology and clinical applications Pharmacological Profile and Therapeutic Uses of Piper Betle Linn.-An Overview Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity Pharmacological aspects of curcumin: review article Pharmacological and Toxicological Properties of Eugenol Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review Pharmacological and bioanalytical aspects of galangin-a concise report review on gentisic acid as a plant derived phenolic acid and metabolite of aspirin: Comprehensive pharmacology, toxicology, and some pharmaceutical aspects Guaijaverin-a plant flavonoid as potential antiplaque agent against Streptococcus mutans Kaempferol: A Key Emphasis to Its Anticancer Potential Distribution and Biological Activities of the Flavonoid Luteolin Effects of chlorogenic acid and its metabolites on spontaneous locomotor activity in mice Bioactive compounds from medicinal plants: Focus on Piper species Review of Swertia chirayita (Gentianaceae) as a Traditional Medicinal Plant Chemical constituents and bio-pharmacological activities of Swertia chirata: A review chemopreventive/anticancer agent: Chemistry and biological effects Pharmacological applications and in vitro biotechnological production of anticancer alkaloids of Catharanthus roseus A review on the pharmacological effects of vitexin and isovitexin Pharmacological and analytical aspects of withaferin A: A concise report of current scientific literature The anti-ulcer effect in rats of ginger constituents The RCSB protein data bank: Integrative view of protein, gene and 3D structural information PubChem substance and compound databases Open Babel: An open chemical toolbox Molecular docking: a powerful approach for structure-based drug discovery Bajorath J) Docking and scoring in virtual screening for drug discovery: methods and applications PatchDock and SymmDock: servers for rigid and symmetric docking Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved αketoamide inhibitors FireDock: a web server for fast interaction refinement in molecular docking Interaction of α-cyperone with human serum albumin: Determination of the binding site by using Discovery Studio and via spectroscopic methods Pymol: An open-source molecular graphics tool Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules ProTox-II: a webserver for the prediction of toxicity of chemicals ProTox: a web server for the in silico prediction of rodent oral toxicity OSIRIS property explorer Swiss Target Prediction: updated data and new features for efficient prediction of protein targets of small molecules Swiss Similarity: A Web Tool for Low to Ultra High Throughput Ligand-Based Virtual Screening Can we contain the COVID-19 outbreak with the same measures as for SARS? SARS-CoV-2 and COVID-19: The most important research questions What we know so far: COVID-19 current clinical knowledge and research Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression Discovering drugs to treat coronavirus disease 2019 (COVID-19) Molecular Docking of Phytoligands to the viral protein receptor, P. Monodon, Rab7 An introduction to the computer-aided structure-based drug design--applications of bioinformatics to drug discovery. Rinsho byori. The Japanese journal of clinical pathology Bioinformatics platform development: from gene to lead compound Antimicrobial activity of flavanoid sulphates and other fractions of Argyreiaspeciosa (Burm. f) Boj Remdesivir as a possible therapeutic option for the COVID-19 Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach Main Protease Inhibitors and Drug Surface Hotspot for the Treatment of COVID-19: Drug Repurposing and Molecular Docking Approach Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and Vina Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus Conglomeration of highly antigenic nucleoproteins to inaugurate a heterosubtypic next generation vaccine candidate against Arenaviridae family. bioRxiv (Preprint) From SARS to MERS: Crystallographic Studies on Coronaviral Proteases Enable Antiviral Drug Design The entry of entry inhibitors: a fusion of science and medicine Asiatic Acid, a Pentacyclic Triterpene From Centellaasiatica, Is Neuroprotective in a Mouse Model of Focal Cerebral Ischemia Asiatic Acid Isolated from Centella Asiatica Inhibits TGF-β1-induced Collagen Expression in Human Keloid Fibroblasts via PPAR-γ Activation Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences Nf-κb-Dependent Inhibition of HIV-1 Transcription by Withaferin A. HIV Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A Natural Withanolides in the Treatment of Chronic Diseases Yndart Arias A. Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions Promising Anti-influenza Properties of Active Constituent of Withaniasomnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study Hypoglycemic Activity of Avicularin and Guaijaverin in Guava Leaves Avicularin Inhibits Lipopolysaccharide-Induced Inflammatory Response by Suppressing ERK Phosphorylation in RAW Macrophages Avicularin Relieves Depressive-Like Behaviors Induced by Chronic Unpredictable Mild Stress in Mice Anti-oxidant activity of avicularin and isovitexin from Lespedeza cuneata Hepatoprotective Effect of Flavonoid Glycosides from Lespedeza cuneata against Oxidative Stress Induced by tert-Butyl Hyperoxide Protective effect of avicularin on rheumatoid arthritis and its associated mechanisms The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Crystal structure of the SARS-CoV-2 non-structural protein 9 Cell entry mechanisms of SARS-CoV-2 Improving early drug discovery through ADME modelling Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response Determination of polar compounds in guava leaves infusions and ultrasound aqueous extract by HPLC-ESI-MS Glycosylated Flavonoids from Psidium guineense as Major Inhibitors of HIV-1 Replication in vitro ADMET-score-a comprehensive scoring function for evaluation of chemical drug-likeness Antioxidant activity of glycowithanolides from Withania somnifera Withanolides from Withania somnifera roots Withaferin A causes FOXO3a-and Bimdependent apoptosis and inhibits growth of human breast cancer cells in vivo Vitro and In Vivo Cytotoxic Effects of Withaferin A on Retinal Epithelial Pigmented Cells Safety and Pharmacokinetics of Withaferin-A in advanced stage high grade Osteosarcoma: A phase I trial Use of hydrocortisone in the treatment of acute myocardial infarction: summary of a clinical trial in 446 patients Spectrophotometric method for diosmin determination Biological effects of myricetin The effect of simvastatin or interferon-α on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals The authors would like to acknowledge the Department of Microbial Biotechnology, and Environmental Biotechnology of Sylhet Agricultural University for technical support. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors declare that they have no conflict of interests. The authors would like to acknowledge the Department of Microbial Biotechnology, Department of Pharmaceuticals and Industrial Biotechnology, and the Department of Plant and Environmental Biotechnology of Sylhet Agricultural University, Sylhet-3100, Bangladesh for the technical support provided for this research work. • Asiatic acid, Avicularin, Guajaverin & Withaferin showed maximum binding affinity • The crucial binding sites & drug surface hotspots were unravelled for key viral protein• ADME analysis revealed that top candidates do not show any undesirable consequences • Witheferin was comparatively toxic with considerable cytotoxicity and immunotoxicity • Hydrocortisone and Simvastatin could be an option to treat SARS-CoV-2 infections. The authors declare that there is no conflict of interest regarding any personal or financial relationships that could inappropriately influence the work.